These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11192530)

  • 1. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
    Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
    Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
    Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
    J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot.
    Gaspar HB; Bradley LA; Katz F; Lovering RC; Roifman CM; Morgan G; Levinsky RJ; Kinnon C
    Hum Mol Genet; 1995 Apr; 4(4):755-7. PubMed ID: 7633429
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase.
    Vorechovský I; Luo L; de Saint Basile G; Hammarström L; Webster AD; Smith CI
    Hum Mol Genet; 1995 Dec; 4(12):2403-5. PubMed ID: 8634718
    [No Abstract]   [Full Text] [Related]  

  • 5. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
    Tsukada S; Witte ON
    Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
    [No Abstract]   [Full Text] [Related]  

  • 6. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.
    Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD
    Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in the diagnosis of X-linked agammaglobulinemia.
    Nonoyama S
    Intern Med; 1999 Sep; 38(9):687-8. PubMed ID: 10480296
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase.
    Mesci L; Ozdag H; Turul T; Ersoy F; Tezcan I; Sanal O
    Turk J Pediatr; 2006; 48(4):362-4. PubMed ID: 17290574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
    Saffran DC; Parolini O; Fitch-Hilgenberg ME; Rawlings DJ; Afar DE; Witte ON; Conley ME
    N Engl J Med; 1994 May; 330(21):1488-91. PubMed ID: 8164701
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.
    Mao C; Zhou M; Uckun FM
    J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
    Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
    FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical X-linked agammaglobulinemia diagnosed in three adults.
    Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
    Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.
    De Weers M; Dingjan GM; Brouns GS; Kraakman ME; Mensink RG; Lovering RC; Schuurman RK; Borst J; Hendriks RW
    Clin Exp Immunol; 1997 Feb; 107(2):235-40. PubMed ID: 9030858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
    Staehelin F; Kühne T
    Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
    Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.